Altimmune, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.03B0.02B0.02B0.03B0.02B0.01B0.01B0.00B0.01B0.01B0.01B0.01B0.00B0.00B0.00B0.00B
Operating items
Depreciation & Amortization - Total 0.00B0.00B0.00B0.00B0.00B0.00B
Research & Development 0.03B0.02B0.02B0.02B0.02B0.01B0.01B0.01B0.02B0.02B0.02B0.05B0.07B0.07B0.07B0.08B
Selling, General & Administrative 0.02B0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.02B
Restructuring Costs 0.00B
Other Operating Expenses 0.00B0.01B0.00B0.19B-0.05B0.02B0.00B0.01B0.01B
Operating Expenses 0.05B0.04B0.04B0.03B0.03B0.02B0.01B0.01B0.06B0.05B0.03B0.06B0.10B0.09B0.10B0.10B
Operating Income -0.03B-0.02B-0.01B-0.01B-0.01B-0.01B-0.00B-0.01B-0.05B-0.04B-0.02B-0.05B-0.10B-0.09B-0.10B-0.10B
EBIT -0.03B-0.02B-0.01B-0.01B-0.01B-0.01B-0.00B-0.01B-0.05B-0.04B-0.02B-0.05B-0.10B-0.09B-0.10B-0.10B
Non-operating items
Non Operating Investment Income -0.00B-0.01B0.01B
Interest & Investment Income 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B
Other Non Operating Income -0.00B-0.01B0.01B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B
Non Operating Income -0.01B0.01B0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B0.01B0.01B
Net income details
EBT -0.02B-0.03B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.05B-0.05B-0.02B-0.05B-0.10B-0.08B-0.09B-0.10B
Tax Provisions 0.00B0.00B0.00B0.00B-0.01B-0.01B-0.00B-0.01B-0.00B
Profit After Tax -0.03B-0.03B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.05B-0.04B-0.02B-0.05B-0.10B-0.08B-0.09B-0.10B
Income from Continuing Operations -0.02B-0.03B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.05B-0.04B-0.02B-0.05B-0.10B-0.08B-0.09B-0.10B
Consolidated Net Income -0.02B-0.03B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.05B-0.04B-0.02B-0.05B-0.10B-0.08B-0.09B-0.10B
Income towards Parent Company -0.02B-0.03B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.05B-0.04B-0.02B-0.05B-0.10B-0.08B-0.09B-0.10B
Preferred Dividend Payments 0.00B0.00B0.00B0.00B
Net Income towards Common Stockholders -0.02B-0.03B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.05B-0.04B-0.02B-0.05B-0.10B-0.08B-0.09B-0.10B
Additional items
EPS (Basic) -241.26-1.08-0.08-0.10-0.23-0.17-0.05-1.66-118.91-15.16-1.60-1.91-2.35-1.81-1.66-1.34
EPS (Weighted Average and Diluted) -0.17-0.052.95-1.91-2.35-1.81-1.66-1.34
Shares Outstanding (Weighted Average) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.02B0.03B0.04B0.05B0.05B0.07B
Shares Outstanding (Diluted Average) 0.06B0.06B0.07B0.03B0.04B0.05B0.05B0.07B
EBITDA 812.00B68.82B-0.01B-0.01B-0.01B-0.01B-0.00B-0.02B-0.04B-0.04B-0.02B-0.05B-0.10B-0.08B-0.09B-0.10B
Interest Expenses -0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Shares Outstanding 305.32B5,339.41B0.05B0.05B0.05B0.06B0.01B0.00B0.00B0.01B0.02B0.04B0.04B0.05B0.07B0.07B
Tax Rate 10.8313.570.289.950.24